Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fertility-preserving neoadjuvant chemotherapy and conservative surgery for FIGO stage IB2–IB3 cervical cancer
jRCTs061250041Recruiting
- Start
- Apr 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of paclitaxel and carboplatin in Cervical Cancer (CC). Primary endpoint: Uterine preservation rate. Started Apr 2026; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCTs061250041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250041.